P153 Tocilizumab in systemic sclerosis: real world experience from a single centre cohort supports potential benefit on lung function for anti-topoisomerase (Scl-70) positive subgroup (2020)
Attributed to:
Functional and molecular diversity of skin fibroblasts in systemic sclerosis.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/rheumatology/keaa111.148
Publication URI: http://dx.doi.org/10.1093/rheumatology/keaa111.148
Type: Journal Article/Review
Parent Publication: Rheumatology
Issue: Supplement_2